Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 27, 2017

DrugPatentWatch Database Preview

Albumin iodinated i-125 serum - Generic Drug Details

« Back to Dashboard

What are the generic sources for albumin iodinated i-125 serum and what is the scope of albumin iodinated i-125 serum patent protection?

Albumin iodinated i-125 serum
is the generic ingredient in three branded drugs marketed by Iso Tex, Mallinckrodt, and Bayer Pharms, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for albumin iodinated i-125 serum. One supplier is listed for this compound.

Summary for Generic Name: albumin iodinated i-125 serum

Tradenames:3
Patents:1
Applicants:3
NDAs:3
Drug Master File Entries: see list6
Suppliers / Packagers: see list1
Clinical Trials: see list2,744
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:albumin iodinated i-125 serum at DailyMed

Pharmacology for Ingredient: albumin iodinated i-125 serum

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Iso Tex
JEANATOPE
albumin iodinated i-125 serum
INJECTABLE;INJECTION017836-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Bayer Pharms
RADIO-IODINATED (I 125) SERUM ALBUMIN (HUMAN)
albumin iodinated i-125 serum
INJECTABLE;INJECTION017846-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Iso Tex
JEANATOPE
albumin iodinated i-125 serum
INJECTABLE;INJECTION017836-001Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe
Mallinckrodt
RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125
albumin iodinated i-125 serum
INJECTABLE;INJECTION017844-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Iso Tex
JEANATOPE
albumin iodinated i-125 serum
INJECTABLE;INJECTION017836-003Jun 8, 2004RXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot